Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

RWJ-676070

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
In recent years, several vasopressin antagonists have been developed that block V1 receptors either selectively or nonselectively… Expand
Is this relevant?
2009
2009
Blockade of the renin-angiotensin system (RAS), the standard treatment for chronic proteinuric nephropathy, slows but may not… Expand
  • table 1
  • figure 2
  • table 2
  • figure 1
  • figure 3
Is this relevant?
2009
2009
(+)-Dapoxetine hydrochloride, [(123)I]-BZA, 9-Aminocamptothecin; Abacavir sulfate/lamivudine, Adalimumab, Adefovir dipivoxil… Expand
Is this relevant?
2008
2008
The dysregulation of arginine vasopressin (AVP) release and activation of vasopressin V(1A) and V(2) receptors may play a role in… Expand
Is this relevant?
2007
2007
We have continued to explore spirobenzazepines as vasopressin receptor antagonists to follow up on RWJ-339489 (2), which had… Expand
Is this relevant?